News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rusnano, US Fund to Invest $760 Million in Pharma Venture


3/6/2012 7:26:33 AM

Russian state technology firm Rusnano is teaming up with a U.S. venture fund to invest around $760 million in a number of U.S. healthcare and pharmaceuticals firms, establish a manufacturing facility in Russia and bring new drugs to the Russian market. As part of the deal, Rusnano and life sciences technologies investor Domain Associates are planning to each invest $330 million in about 20 US-based healthcare technology companies. Rusnano, a $10 billion technology fund, and Domain, with 2.4 billion of capital under management, will also fund a pharmaceutical and medical device manufacturing facility in Russia.

Read at Reuters
Read at Nanowerk
Read at Bloomberg


comments powered by Disqus
Reuters
Nanowerk
Bloomberg
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES